Innocan Pharma Moves Forward with Share Consolidation Plans

Innocan Pharma's Share Consolidation Announcement

Innocan Pharma Corporation (CSE: INNO, OTCQB: INNPF) has announced an important step regarding its shares, aiming for enhanced market presence and stability. The company is set to consolidate its issued and outstanding common shares at a ratio of 1 post-consolidation Common Share for every 65 pre-consolidation shares. This decision follows its recent press release and is aimed at improving the perceived value of the company’s equity and to facilitate its upcoming public offering in the U.S.

Details of the Consolidation

The Share Consolidation will play a significant role in Innocan's strategic plan leading towards its proposed public offering. This offering includes the sale of 'Units', each comprising one common share and a common share purchase warrant. Shareholders approved this consolidation at a recent meeting, and the company's board is now working on the liquidation ratio.

The Upcoming Public Offering

Innocan plans to list its Common Shares and Warrants on the NASDAQ Capital Market under the ticker symbols 'INNP' and 'INNPW'. With ThinkEquity LLC serving as the representative underwriter for this offering, the company is focusing on enhancing its reach in the U.S. market. This strategic move aims to attract more investment and provide additional capital for ongoing projects.

Investor Benefits and Potential Outcomes

Upon completion of the Share Consolidation, Innocan expects to reduce its existing shares from approximately 292 million to about 4.5 million, subject to rounding. This consolidation is vital as it prepares the company for the anticipated increase in share value, setting a foundation for future offerings. The consolidation aims to attract higher-profile investors who look for stability in investment opportunities.

Further Insights from the CEO

Iris Bincovich, the CEO of Innocan, expressed positivity regarding the consolidation, stating that it marks a critical phase in their journey towards a successful U.S. public offering and NASDAQ listing. The initiative not only aims at administrative restructuring but also indicates the management’s confidence in increasing investor value through strategic consolidation.

What Happens Next?

As the Share Consolidation process moves forward, registered shareholders will receive a letter of transmittal which will detail how to exchange their old shares for the new post-consolidation shares. There are specific procedures for shareholders holding stocks through intermediaries, prompting them to reach out to their brokers for guidance.

About Innocan Pharma

Innocan Pharma is an innovator in the pharmaceutical and wellness sphere, focusing on developing cutting-edge products that utilize CBD for a variety of therapeutic applications. The company operates through a specialized CBD-loaded liposome drug delivery platform designed for precise dosing and sustained, controlled release of active ingredients, bolstering its standing in non-opioid pain management.

Contact Information

For additional information, interested parties can reach out to Iris Bincovich, CEO, via phone at +15162104025 or +972-54-3012842, or by email at info@innocanpharma.com.

Frequently Asked Questions

What is the purpose of the share consolidation?

The share consolidation is intended to streamline the company's equity and enhance its market presence as it prepares for a public offering.

When will the consolidation take effect?

The consolidation is expected to take effect following board approval and regulatory compliance, with trading on a post-consolidation basis to commence shortly thereafter.

How many shares will be available post-consolidation?

Following the consolidation, the total number of shares will be approximately 4.5 million, a significant reduction from the current amount.

What does this mean for current shareholders?

Current shareholders will exchange their pre-consolidation shares for a reduced number of post-consolidation shares, which is expected to increase in value.

Who can I contact for more information?

Shareholders can contact Iris Bincovich, CEO, for more information or clarification about the consolidation and upcoming offering.

About The Author

Greetings, I'm 32-year-old author and financial specialist Evelyn Baker. My introduction into the financial industry started with an economics degree and continued with a wealth of experience in wealth management and financial consulting. My great passion over the years has been assisting people and companies in making wise, well-informed decisions to reach their financial objectives.

My goal with writing is to simplify difficult financial ideas into understandable, doable guidance. My goal in writing many books and articles is to make personal finance understandable to everyone, irrespective of their experience or background. I want to give readers the information they need to take charge of their financial futures, from investing and retirement planning to budgeting and saving.

Along with my writing, I lead webinars and workshops where I provide doable advice and methods for achieving financial success. To reach a larger audience, I also frequently contribute to financial blogs and publications. My method is always to offer doable, real-world guidance that can actually improve people's lives.

Aside from my job, I like to cook, travel, and experience other cultures. I work hard to apply my belief in the value of a balanced life to my financial counsel. My goal in working is to encourage and enable people to succeed financially so they may lead the best lives possible.

Contact Evelyn Baker privately here. Or send an email with ATTN: Evelyn Baker as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.